Klaus Kutz
Chief Tech/Sci/R&D Officer bij PROPANC BIOPHARMA, INC.
Profiel
Klaus Kutz is associated with Propanc Biopharma, Inc., the University of Bonn, and RESprotect GmbH.
He holds the position of Chief Medical Officer at Propanc Biopharma, Inc. and RESprotect GmbH, and is a Professor at the University of Bonn.
Actieve functies van Klaus Kutz
| Bedrijven | Functie | Begin |
|---|---|---|
| PROPANC BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
RESprotect GmbH
 RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Chief Tech/Sci/R&D Officer | 24-11-2009 |
| University of Bonn | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PROPANC BIOPHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
RESprotect GmbH
RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Health Technology |
